CCME Global approves ₹196.32cr issue, 1:10 split FY26

The headline decisions from CCME Global’s board

CCME Global Limited (BSE: 514336), formerly Genesis IBRC India Limited, has cleared a set of corporate actions that combine fundraising, overseas acquisitions, and a stock split. The company said its Board of Directors met on Saturday, August 29, 2026, to consider and approve steps around capital raising and expansion.

The company’s disclosures show the board’s agenda included an increase in authorised share capital, a preferential issue, a sub-division of shares, and a review of entity acquisitions. It also included FY26 approvals, AGM logistics, and a proposal to shift the registered office from Andhra Pradesh to Maharashtra.

Board meeting context: from intimation to outcome

Ahead of the meeting, CCME Global had informed the exchange that the August 29 board meeting would take up fundraising through equity shares or eligible securities on a preferential basis, subject to approvals. The agenda also listed capital structure changes such as an authorised capital increase, alteration to Clause V of the Memorandum of Association, and a share sub-division.

Alongside fundraising and capital actions, the board was scheduled to consider FY26 financial results for the year ended March 31, 2026, and approve the Directors’ Report with annexures. The same agenda also allowed for discussions on acquisitions and the proposed registered-office shift.

Preferential issue: what the company approved

A key outcome was the approval of a preferential equity issue aggregating up to ₹196.32 crore. The company described the core objective as creation, offer, issue, and allotment of equity shares on a preferential basis.

The disclosure breaks the issuance into components, including a cash portion and share swaps linked to acquisitions. The issue price cited in the breakdown is ₹10 per share. While the company stated an aggregate figure of up to ₹196.32 crore for the preferential issue, the disclosed components below represent specific tranches linked to cash and swap considerations.

How the share issuance is structured (cash and swaps)

The preferential allotment proposal includes issuance of equity shares for cash and for non-cash consideration through swaps. The company detailed three components: a cash raise, Swap 1 shares for a stake purchase in a UAE entity, and Swap 2 shares for a stake purchase in another UAE entity.

The structure, as disclosed, is summarised below.

Acquisitions: majority stakes in UAE FMCG distributors

CCME Global said it approved acquisitions of majority stakes in two UAE-based entities to expand its FMCG distribution footprint in the Middle East and Africa. One transaction involves Cash & Carry Middle East FZCO, also referred to in the disclosures as CCME UAE in the context of acquiring a controlling interest.

For Cash & Carry Middle East FZCO, the company approved acquisition of a 45% stake via share swap for ₹112.73 crore. It also approved acquisition of an additional 6% stake via cash consideration of up to ₹15 crore. The company stated the total cost of acquisition as ₹127.73 crore, and separately described it as acquiring more than 50% of CCME UAE through a mix of swap and cash.

The second transaction involves Interlink Distribution LLC, where CCME Global approved the purchase of 52% stake via share swap for ₹20.34 crore.

Stock split: 1 share of ₹10 into 10 shares of ₹1

The board approved a sub-division of equity shares in a 1:10 ratio. Specifically, one equity share of face value ₹10 is to be split into ten equity shares of face value ₹1 each.

The company said the move is intended to enhance liquidity and make the shares more affordable for smaller investors. It also disclosed that post-split, the authorised share capital will remain ₹200 crore.

In the same context, the company disclosed issued and paid-up capital at ₹196.32 crore post-allotment.

FY26 approvals and AGM date

Directors approved the Directors’ Report and financial results for FY26 (year ended March 31, 2026). The company also scheduled its 34th Annual General Meeting for Tuesday, September 29, 2026, to be held through video conferencing.

The board agenda had also included consideration of a final dividend. However, the disclosures provided do not specify any dividend recommendation, record date, or ex-date.

Board-level changes: chairperson transition and committee reshuffle

Separately, the company disclosed board changes effective August 21, 2026. CCME Global appointed Ms. Ami Oza as Chairperson and as an Additional Independent Non-Executive Director with effect from August 21, 2026.

Ms. Ritika Agrawal resigned from the Chairperson role, citing proposed realignment of board responsibilities and other business commitments, while continuing as an Independent Non-Executive Director. The company also stated there were no other material reasons for her resignation from the chairperson position.

Following the change, CCME Global reconstituted key committees including the audit committee, nomination and remuneration committee, and stakeholder relationship committee.

Financial snapshot: Q1 FY27 numbers and audit appointments

In the board outcome for August 21, 2026, CCME Global approved its Q1 FY27 financial results. The company reported a net loss of ₹0.2642 crore for Q1 FY27, compared with a net loss of ₹0.1181 crore in Q1 FY26. Basic EPS for Q1 FY27 stood at (₹0.06), compared with (₹0.09) in Q1 FY26.

The board also appointed GJMS & Associates LLP as internal auditors for FY27. In a separate July 2026 disclosure, the company said it appointed Desai Saksena & Associates as statutory auditors to fill a casual vacancy caused by the resignation of M. S. Rao & Associates LLP, effective July 15, 2026.

Key dates and disclosures at a glance

Market impact: what these actions change for investors

The combination of a preferential issue and share-swap acquisitions indicates CCME Global is using equity as a key currency for expansion. The disclosed structure includes both a cash component (₹18 crore) and non-cash issuance linked to specific stake purchases in UAE entities.

The 1:10 stock split changes the number of shares outstanding and the face value, but not the underlying value of shareholders’ holdings. The company explicitly linked the split to liquidity and affordability, which typically matters for trading activity, especially when a stock is priced at levels that can limit participation by smaller investors.

Investors will likely track shareholder approvals and regulatory steps required for the preferential issue, acquisitions, and capital structure changes. They will also watch AGM outcomes, given the meeting is where certain approvals and corporate actions are commonly placed for shareholder consent.

Why this matters: capital allocation and governance signals

The approvals combine three themes: governance changes at the board level, capital raising through preferential issuance, and inorganic expansion through acquisitions. The chairperson transition and committee reconstitution were disclosed as part of a board realignment, following a period that also included the reported demise of Independent Non-Executive Director Mr. Ashok Chhaganbhai Patel on August 15, 2026.

On capital allocation, the company’s disclosures emphasise acquisitions designed to expand an FMCG distribution footprint in the Middle East and Africa. The preferential issue, including share swaps, shows the board’s intention to pursue these transactions with a defined consideration mechanism and disclosed pricing in the allotment structure.

Conclusion

CCME Global’s August 2026 board actions bring together a preferential issue of up to ₹196.32 crore, acquisitions in the UAE distribution space, and a 1:10 stock split, alongside routine FY26 approvals and AGM scheduling. With the AGM set for September 29, 2026, investors will be watching for the shareholder and regulatory approvals needed to execute the fundraising, acquisition, and capital structure proposals.